Invenomic Capital Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-210,332
| Closed | -$4.77M | – | 148 |
|
|
2023
Q4 | $4.77M | Buy |
210,332
+116,679
| +125% | +$2.64M | 0.22% | 106 |
|
|
2023
Q3 | $1.74M | Buy |
+93,653
| New | +$1.74M | 0.07% | 132 |
|
|
2022
Q4 | – | Sell |
-140,312
| Closed | -$3.34M | – | 139 |
|
|
2022
Q3 | $3.34M | Sell |
140,312
-3,975
| -3% | -$94.6K | 0.29% | 97 |
|
|
2022
Q2 | $3.22M | Buy |
+144,287
| New | +$3.22M | 0.23% | 98 |
|